Page 579 - Read Online
P. 579

Kiss et al. Mini-invasive Surg 2021;5:55  https://dx.doi.org/10.20517/2574-1225.2021.70  Page 7 of 9

               CONCLUSION
               The use of robotic systems enabled the implication of the advantages of mini-invasive surgery even in more
               complex cases. As the conclusions of studies are still not consistent, robotic myomectomy tends to show
               superiority in many factors over laparoscopy and open surgery. Operating time and higher cost seem to be
               the major drawback, but with the application of the presented surgical techniques and steep learning curve
               these could be rapidly minimized. Robotic single-site surgery seems to be a further step to reduce morbidity
               and pain and enhance cosmetic outcomes of minimal invasive techniques. This latest surgical access seems
               to be a feasible and safe procedure for myomectomy, which could replace conventional laparoscopy and
               robotic multiport surgeries even in complicated cases.

               DECLARATIONS
               Authors’ contributions
               Made substantial contributions to concept and design of the article: Kiss I, Svobodova P, Karasek L,
               Svoboda B
               Drafted the article: Kiss I, Svobodova P
               Critical revision of the article: Svobodova P, Karasek L, Svoboda B

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2021.


               REFERENCES
               1.       Stewart  EA,  Cookson  CL,  Gandolfo  RA,  Schulze-Rath  R.  Epidemiology  of  uterine  fibroids:  a  systematic  review.  BJOG
                   2017;124:1501-12.  DOI  PubMed
               2.       Bulun SE. Uterine fibroids. N Engl J Med 2013;369:1344-55.  DOI  PubMed
               3.       Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007;87:725-36.  DOI  PubMed
               4.       Vlahos NF, Theodoridis TD, Partsinevelos GA. Myomas and adenomyosis: impact on reproductive outcome. Biomed Res Int
                   2017;2017:5926470.  DOI  PubMed  PMC
               5.       Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal
                   uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J
                   Gynaecol Obstet 2018;143:393-408.  DOI  PubMed
               6.       Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016;22:665-86.  DOI
                   PubMed  PMC
               7.       Donnez J, Arriagada P, Donnez O, Dolmans MM. Emerging treatment options for uterine fibroids. Expert Opin Emerg Drugs
                   2018;23:17-23.  DOI  PubMed
               8.       Wang T, Tang H, Xie Z, Deng S. Robotic-assisted vs. laparoscopic and abdominal myomectomy for treatment of uterine fibroids: a
                   meta-analysis. Minim Invasive Ther Allied Technol 2018;27:249-64.  DOI  PubMed
               9.       Ranes M, Carlan SJ, Vaught J, Greves CE. Robot-assisted laparoscopic myomectomy versus abdominal myomectomy a retrospective
   574   575   576   577   578   579   580   581   582   583   584